| Nanoparticles: pharmacological and toxicological significance C Medina, MJ Santos‐Martinez, A Radomski, OI Corrigan, MW Radomski British journal of pharmacology 150 (5), 552-558, 2007 | 1015 | 2007 |
| Nanoparticle‐induced platelet aggregation and vascular thrombosis A Radomski, P Jurasz, D Alonso‐Escolano, M Drews, M Morandi, ... British journal of pharmacology 146 (6), 882-893, 2005 | 822 | 2005 |
| The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats A Radomski, G Sawicki, DM Olson, MW Radomski British journal of pharmacology 125 (7), 1455, 1998 | 112 | 1998 |
| Increased activity and expression of matrix metalloproteinase-9 in a rat model of distal colitis C Medina, S Videla, A Radomski, MW Radomski, M Antolín, F Guarner, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 284 (1 …, 2003 | 110 | 2003 |
| Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets A Radomski, P Jurasz, EJ Sanders, CM Overall, HF Bigg, DR Edwards, ... British journal of pharmacology 137 (8), 1330, 2002 | 101 | 2002 |
| Nanopharmacology and nanotoxicology of nanomaterials:new challenges and opportunities A Radomska, J Leszczyszyn, M Radomski Advances in Clinical and Experimental Medicine 25, 151-162, 2016 | 98* | 2016 |
| Nitric oxide activates chloride currents in human lung epithelial cells B Kamosinska, MW Radomski, M Duszyk, A Radomski, SF Man American Journal of Physiology-Lung Cellular and Molecular Physiology 272 (6 …, 1997 | 92 | 1997 |
| Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance A Radziwon‐Balicka, C Medina, L O'driscoll, A Treumann, D Bazou, ... British journal of pharmacology 167 (4), 787-804, 2012 | 82 | 2012 |
| Platelet–leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases AWY Chung, A Radomski, D Alonso-Escolano, P Jurasz, MW Stewart, ... British journal of pharmacology 143 (7), 845, 2004 | 78 | 2004 |
| Targeted delivery of transferrin-conjugated liposomes to an orthotopic model of lung cancer in nude rats MM Gaspar, A Radomska, OL Gobbo, U Bakowsky, MW Radomski, ... Journal of aerosol medicine and pulmonary drug delivery 25 (6), 310-318, 2012 | 75 | 2012 |
| Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts I Mayers, T Hurst, L Puttagunta, A Radomski, T Mycyk, G Sawicki, ... The Journal of thoracic and cardiovascular surgery 122 (4), 746-752, 2001 | 72 | 2001 |
| Nonremodeling properties of matrix metalloproteinases: the platelet connection P Jurasz, AWY Chung, A Radomski, MW Radomski Circulation research 90 (10), 1041-1043, 2002 | 68 | 2002 |
| Differential release of matrix metalloproteinase‐9 and nitric oxide following infusion of endotoxin to human volunteers J Albert, A Radomski, A Soop, A Sollevi, C Frostell, MW Radomski Acta anaesthesiologica scandinavica 47 (4), 407-410, 2003 | 66 | 2003 |
| Protein kinase Cδ mediates platelet-induced breast cancer cell invasion D Alonso-Escolano, C Medina, K Cieslik, A Radomski, P Jurasz, ... Journal of Pharmacology and Experimental Therapeutics 318 (1), 373-380, 2006 | 63 | 2006 |
| Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis P Jurasz, MJS MARTINEZ, A Radomska, MW Radomski Journal of Thrombosis and Haemostasis 4 (5), 1095-1106, 2006 | 61 | 2006 |
| Platelet compatibility of PLGA, chitosan and PLGA–chitosan nanoparticles X Li, A Radomski, OI Corrigan, L Tajber, F De Sousa Menezes, S Endter, ... Nanomedicine 4 (7), 735-746, 2009 | 58 | 2009 |
| Pharmacological characteristics of solid-phase von Willebrand factor in human platelets A Radomski, MW Stewart, P Jurasz, MW Radomski British journal of pharmacology 134 (5), 1013, 2001 | 53 | 2001 |
| Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin P Jurasz, MW Stewart, A Radomski, F Khadour, M Duszyk, MW Radomski British journal of pharmacology 134 (5), 1104, 2001 | 49 | 2001 |
| Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide A Martinez, E Salas, A Radomski, MW Radomski Med Sci Monit 7 (4), 646-651, 2001 | 41 | 2001 |
| Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups M Jones, I Inkielewicz, C Medina, MJ Santos-Martinez, A Radomski, ... Journal of medicinal chemistry 52 (21), 6588-6598, 2009 | 40 | 2009 |
